ロード中...
Self-adjuvanting nanoemulsion targeting dendritic cell receptor Clec9A enables antigen-specific immunotherapy
Non–antigen-specific stimulatory cancer immunotherapies are commonly complicated by off-target effects. Antigen-specific immunotherapy, combining viral tumor antigen or personalized neoepitopes with immune targeting, offers a solution. However, the lack of flexible systems targeting tumor antigens t...
保存先:
| 出版年: | J Clin Invest |
|---|---|
| 主要な著者: | , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Clinical Investigation
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5919883/ https://ncbi.nlm.nih.gov/pubmed/29485973 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI96791 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|